Application of assisted reproductive technology programs in a female patient with systemic lupus erythematosus and antiphospholipid syndrome

Kosheleva N.M., Perminova S.G., Vlasova G.A., Kirillova A.O.

1 V.A. Nasonova Research Institute of Rheumatology, Ministry of Science and Higher Education of Russia, Moscow, Russia; 2 Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia, Moscow, Russia
Background. Patients with systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS) often face the problems related to their reproductive function; in this connection many patients undergo assisted reproductive technology (ART) programs. However, the challenges in implementing the ART programs in this group of patients include diminished ovarian reserve due to the treatment received, as well as the risk of an exacerbation of the underlying disease and thrombosis.
Case report. This describes a case of a successfully implemented in vitro fertilization (IVF) program, followed by embryo cryopreservation in the patient with severe SLE and APS and a family obstetric/gynecological history.
Conclusion. The authors describe the stages of the IVF program in the modified clinical and embryological protocol for ovarian stimulation with gonadotropin-releasing hormone antagonists and subsequent embryo cryopreservation, as well as the measures to prevent complications of the underlying disease.

Keywords

systemic lupus erythematosus
antiphospholipid syndrome
infertility
assisted reproductive technologies
in vitro fertilization
thrombosis

References

  1. Østensen M. Sexual and reproductive health in rheumatic disease. Nat. Rev. Rheumatol. 2017; 13(8): 85-93. https://dx.doi.org/10.1038/nrrheum.2017.102.
  2. Guidelines for referral and management of systemic lupus erythematosus in adults. American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Guidelines. Arthritis Rheum. 1999; 42(9): 1785-96. https://dx.doi.org/10.1002/1529-0131(199909)42:9<1785::AID-ANR1>3.0.CO;2-#.
  3. Baker W.F. Jr, Bick R.L. The clinical spectrum of antiphospholipid syndrome. Hematol. Oncol. Clin. North Am. 2008; 22(1): 33-52, v-vi. https://dx.doi.org/10.1016/j.hoc.2007.10.007.
  4. Rahman A., Isenberg D.A. Systemic lupus erythematosus. N. Engl. J. Med. 2008; 358(9): 929-39. https://dx.doi.org/10.1056/NEJMra071297.
  5. Насонов Е.Л., ред. Ревматология. Российские клинические рекомендации. М.: ГЭОТАР-Медиа; 2017. 456 с. [Nasonov E.L., ed. Revmatologiya. Rossiiskie klinicheskie rekomendatsii. Moscow: GEOTAR-Media; 2017. 456p. (in Russian).]
  6. Lahita R.G. The role of sex hormones in systemic lupus erythematosus. Curr. Opin. Rheumatol. 1999;11(5): 352-6. https://dx.doi.org/10.1097/00002281-199909000-00005.
  7. Oktem O., Hande Y., Hale B., Bulent U. Reproductive aspects of systemic lupus erythematosus. J. Reprod. Immunol. 2016; 117: 57-65. https://dx.doi.org/10.1016/j.jri.2016.07.001.
  8. Lee T.P., Chiang B.L. Sex differences in spontaneous versus induced animal models of autoimmunity. Autoimmun. Rev. 2012; 11(6-7): A422-9. https://dx.doi.org/10.1016/j.autrev.2011.11.020.
  9. Andreoli L., Crisafulli F., Tincani A. Pregnancy and reproductive aspects of systemic lupus erythematosus. Curr. Opin. Rheumatol. 2017; 29(5): 473-9. https://dx.doi.org/10.1097/BOR.0000000000000415.
  10. Clowse M.E., Chakravarty E., Costenbader K.H., Chambers C., Michaud K. Effects of infertility, pregnancy loss, and patient concerns on family size of women with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Care Res. (Hoboken). 2012; 64(5): 668-74. https://dx.doi.org/10.1002/acr.21593.
  11. Lawrenz B., Henes J., Henes M., Neunhoeffer E., Schmalzing M., Fehm T. et al. Impact of systemic lupus erythematosus on ovarian reserve in premenopausal women: evaluation by using anti-Muellerian hormone. Lupus. 2011; 20(11): 1193-7. https://dx.doi.org/10.1177/0961203311409272.
  12. Medeiros P.B., Febronio M.V., Bonfa E., Borba E.F., Takiuti A.D., Silva C.A. Menstrual and hormonal alterations in juvenile systemic lupus erythematosus. Lupus. 2009;18(1): 38-43. https://dx.doi.org/10.1177/0961203308094652.
  13. LaBarbera A.R., Miller M.M., Ober C., Rebar R.W.. Autoimmune etiology in premature ovarian failure. Am. J. Reprod. Immunol. Microbiol. 1988; 16(3): 115-22.
  14. Blanco-Favela F., Quintal-Alvarez G., Leanos-Miranda A. Association between prolactin and disease activity in systemic lupus erythematosus. Influence of statistical power. J. Rheumatol. 1999; 26(1): 55-9.
  15. Silva C.A., Deen M.E., Febronio M.V., Oliveira S.K., Terreri M.T., Sacchetti, S.B. et al. Hormone profile in juvenile systemic lupus erythematosus with previous or current amenorrhea. Rheumatol. Int. 2011; 31(8): 1037-43. https://dx.doi.org/10.1007/s00296-010-1389-2.
  16. Ioannidis J.P., Katsifis G.E., Tzioufas A.G., Moutsopoulos H.M. Predictors of sustained amenorrhea from pulsed intravenous cyclophosphamide in premenopausal women with systemic lupus erythematosus. J. Rheumatol. 2002; 29(10): 2129-35.
  17. Oktem O., Oktay K. A novel ovarian xenografting model to characterize the impact of chemotherapy agents on human primordial follicle reserve. Cancer Res. 2007;67(21): 10159-62. https://dx.doi.org/10.1158/0008-5472.CAN-07-2042.
  18. Crawford N.M., Steiner A.Z. Age-related infertility. Obstet. Gynecol. Clin. North Am. 2015; 42(1): 15-25. https://dx.doi.org/10.1016/j.ogc.2014.09.005.
  19. Levine A.B., Lockshin M.D. Assisted reproductive technology in SLE and APS. Lupus. 2014; 23(12): 1239-41. https://dx.doi.org/10.1177/0961203314527370.
  20. Reynaud Q., Lega J.C., Mismetti P., Chapelle C., Wahl D., Cathebras P., Laporte S. Risk of venous and arterial thrombosis according to type of antiphospholipid antibodies in adults without systemic lupus erythematosus: a systematic review and meta-analysis. Autoimmun Rev. 2014; 13(6): 595-608. https://dx.doi.org/10.1016/j.autrev.2013.11.004.
  21. Bellver J., Pellicer A. Ovarian stimulation for ovulation induction and in vitro fertilization in patients with systemic lupus erythematosus and antiphospholipid syndrome. Fertil. Steril. 2009; 92(6): 1803-10. https://dx.doi.org/10.1016/j.fertnstert.2009.06.033.
  22. Reggia R., Sebbar H., Andreoli L. et al. Infertility and assisted reproductive technologies: a multicenter study in patients with SLE and APS. Clin. Exp. Rheumatol. 2016; 34(4, Suppl.99): P1:05, S-50. (10th European Lupus Meeting – Abstracts Venice, Italy - 5-8 October 2016)
  23. Henriksson P., Westerlund E., Wallén H., Brandt L., Hovatta O., Ekbom A. Incidence of pulmonary and venous thromboembolism in pregnancies after in vitro fertilisation: cross sectional study. BMJ. 2015; 346: e8632. https://dx.doi.org/10.1136/bmj.e8632.
  24. Andreoli L., Bertsias G.K., Agmon-Levin N., Brown S., Cervera R., Costedoat-Chalumeau N. et al. EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome, Ann. Rheum. Dis. 2017; 76(3): 476-85. https://dx.doi.org/10.1136/annrheumdis-2016-209770.

Received 04.02.2020

Accepted 07.02.2020

About the Authors

Nadezhda M. Kosheleva, MD, Rheumatologist, PhD, Senior scientific researcher of the Laboratory of Vascular Rheumatology, V.A. Nasonova Research Rheumatology Institute. Tel.: +7(495)109-29-10. E-mail:nadkosheleva@yandex.ru.
34A, Kashirskoye Shosse, Moscow, 115522, Russian Federation.
Svetlana G. Perminova, MD, PhD, Leading researcher of 1-st gynecology department, Research Center of Obstetrics, Gynecology and Perinatology named after Academician V.I. Kulakov. Tel.: +7(916)202-16-87. E-mail: perisvet@list.ru.
4, Oparina str., Moscow, 117997, Russian Federation.
Galina A. Vlasova, graduate student of 1-st gynecology department, Research Center of Obstetrics, Gynecology and Perinatology named after Academician V.I. Kulakov.
Tel.: +7(906)079-44-49. E-mail: galinavlasova089@gmail.com.
4, Oparina str., Moscow, 117997, Russian Federation.
Anastasia O. Kirillova, PhD, Senior researcher, 1-st gynecology department, Research Center of Obstetrics, Gynecology and Perinatology named
after Academician V.I. Kulakov. Tel.: +7(926)781-55-24. E-mail: a_kozyreva@oparina4.ru. 4, Oparina str., Moscow, 117997, Russian Federation. 18

For citation: Kosheleva N.M., Perminova S.G., Vlasova G.A., A.O. Kirillova A.O. Application of assisted reproductive technology programs in a female patient with systemic lupus erythematosus and antiphospholipid syndrome.
Akusherstvo i Ginekologiya/ Obstetrics and gynecology. 2020; 4: 224-229. (In Russian).
https://dx.doi.org/10.18565/aig.2020.4.224-229

Similar Articles

By continuing to use our site, you consent to the processing of cookies that ensure the proper functioning of the site.